Verily's reshuffling Verily spun out of Google's moonshot group in 2015 and remained part of Alphabet's collection of long-term businesses, sometimes called "other bets." Under its then-CEO Andy ...

When Dr. Amy Abernethy joined Verily in July, her goal was to "catapult" the company's clinical-research business into its next phase, company CEO Andy Conrad said at the time. The Google spin-off ...

Verily, the life sciences company owned by Google parent Alphabet, has teamed up with Novartis, Sanofi, Otsuka, and Pfizer on a project that aims to speed up clinical trials.

MSD is teaming up with Verily (formerly Google Life Sciences) and England's national health service on a 'Long Term Conditions Early Intervention' programme. The pilot is just one of five 'Test ...